NAYA Biosciences Inc - NAYA Future Profit

NAYA (NAYA Biosciences Inc) - company brandmark

The expected financial results of NAYA Biosciences (NAYA) demonstrate a trend where represents the current metric. The business relies on a unique antibody creation system that establishes a long-term foundation for the development of targeted drugs. High potential pricing power is driven by the FLEX-NK platform, which activates immune cells. However, the lack of steady cash flow leaves the company dependent on external investments during the early trial period.

NAYA: nayabiosciences.com Future Profit 07/04/2022 - 11/17/2026

NAYA Bio - analytical breakdowns and key metrics (NAYA)

Fundamental company analysis:NAYA, NAYA Bio
Core merchandise of NAYA Biosciences Inc

This indicator assesses the risk of a "value trap" by analyzing the dynamics of expected earnings to avoid betting on the perceived cheapness of an asset. For NAYA Biosciences (NAYA), the stability of these forecasts depends directly on the reliability of diversified biocomponent supply chains. By examining the projected net income metric, an investor can discern market expectations regarding the monetization of scientific developments. The trend in the projected net income metric reflects the business's resilience to operational shocks, allowing for an objective assessment of the company's fundamental value.

Competing companies

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Aura Biosciences, Inc. AURA|Projected Future Earnings CADL|Projected Future Earnings Accuray (ARAY)|Expected Profit SELLAS Life Sciences Group Inc. SLS|ACTU - Future Profit|CTOR: Future Profit|Expected Net Income HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Future Profit|Expected Net Profit Fate Therapeutics Corp (FATE)|Future Profit WHWK|Net Profit Forecast TCRX (TScan Therapeutics, Inc.)|Projected Future Earnings CSBR|XBIT - Expected Net Profit|CEL-SCI Corporation - Future Profit|Expected Net Income OSTX|radiopharmtheranostics.com - Projected Future Earnings|ARTV: Expected Profit|ANL (adlainortye.com) - Future Profit|VERU - Company Profit Forecast|TPST (Tempest Therapeutics, Inc.) - Projected Future Earnings|Projected Future Earnings xiliotx.com|Expected Profit Enochian BioSciences (RENB)|Expected Profit MURA (Mural Oncology PLC)|Expected Profit Kairos Pharma Ltd KAPA|Projected Future Earnings OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Projected Future Earnings|Company Profit Forecast Curis CRIS|APLM: Projected Future Earnings|Future Profit Tharimmune, Inc.|ADVB (Advanced Biomed) - Projected Future Earnings|Genprex - Forward Earnings|Expected Profit calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Expected Net Income|Projected Future Earnings XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Expected Net Profit|PPBT: Future Profit|Expected Net Income AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Expected Profit|Checkpoint Therapeutics, Inc (CKPT) - Projected Future Earnings|Expected Profit Elevation Oncology, Inc.|ICAD: Expected Net Income|Expected Profit ikenaoncology.com (IKNA)|Expected Profit NTBL (Notable Labs, Ltd.)|Projected Future Earnings VIRX (viracta.com)|MOR - Future Profit|AAPGV - Expected Profit